Evidence for beneficial effects of compromised gastric inhibitory polypeptide action in obesity-related diabetes and possible therapeutic implications. (Q37521930)
scientific article published on 17 June 2009
Language:
(P31) (Q13442814)
(P50) (Q39031209)
(Q39048924)
(P304) 1724-1731
(P407) (Q1860)
(P433) 9
(P478) 52
(P577) Wednesday, June 17, 2009
(P921) (Q12174)
(P1433) (Q5270140)
(P1476) "Evidence for beneficial effects of compromised gastric inhibitory polypeptide action in obesity-related diabetes and possible therapeutic implications" (language: en)
(P2093) N Irwin
P R Flatt
(P2860) (Q51673715)
(Q38356895)
(Q44286265)
(Q44244716)
(Q37105136)
(Q44764978)
(Q28510783)
(Q39599495)
(Q38288099)
(Q38292533)
(Q36259482)
(Q45114419)
(Q44992657)
(Q27300376)
(Q38301976)
(Q46949667)
(Q70760508)
(Q28304006)
(Q51168864)
(Q29617302)
(Q34813427)
(Q28371939)
(Q57591390)
(Q28300925)
(Q35824086)
(Q30478488)
(Q47744392)
(Q40784305)
(Q58448374)
(Q36846114)
(Q38323148)
(Q80678035)
(Q46567054)
(Q46116312)
(Q38359890)
(Q51749947)
(Q44660849)
(Q46123434)
(Q38300997)
(Q43867550)
(Q67339179)
(Q51495618)
(Q41011734)
(Q37345249)
(Q34106543)
(Q35579570)
(P13046) (Q7318358)
other details
description scientific article published on 17 June 2009

External Links